EGFR and colorectal carcinoma: In addition to oncogenic mutations and signaling pathways, such as EGFR, TGFβ, and Wnt, in regulating CRC progression, a microenvironmental status with metabolic disorders, including chronic inflammatory bowel syndrome, type 2 diabetes, and obesity, generates a higher risk of CRC progression 7, 8.